C. De-duve, Lysosomes revisited, European Journal of Biochemistry, vol.49, issue.3, pp.391-397, 1983.
DOI : 10.1111/j.1432-1033.1983.tb07841.x

S. Zeiher and . Dimmeler, Cathepsin L is required for endothelial progenitor cell-induced neovascularization, Nat. Med, vol.11, pp.206-213, 2005.

C. Ploegh, A. Y. Peters, and . Rudensky, Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus, Science, vol.280, pp.450-453, 1998.

M. Hess, K. Evers, and . Figura, Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells, EMBO J, vol.14, pp.3599-3608, 1995.

M. Koike, H. Nakanishi, P. Saftig, J. Ezaki, K. Isahara et al., Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons, Neuroscience Research, vol.38, pp.6898-6906, 2000.
DOI : 10.1016/S0168-0102(00)81020-2

H. Nakanishi, J. Zhang, M. Koike, T. Nishioku, Y. Okamoto et al., Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice, J. Neurosci, vol.21, pp.7526-7533, 2001.

E. Momoi, C. Kominami, K. Peters, P. Von-figura, Y. Saftig et al., Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice, Mol. Cell. Neurosci, pp.22-146, 2003.

V. Laurent-matha, S. Maruani-herrmann, C. Prébois, M. Beaujouin, M. Glondu et al., Catalytically inactive human cathepsin D triggers fibroblast invasive growth, The Journal of Cell Biology, vol.2, issue.3, pp.489-499, 2005.
DOI : 10.1038/sj.bjc.6690675
URL : https://hal.archives-ouvertes.fr/inserm-00153783

N. Fehrenbacher and M. Jaattela, Lysosomes as targets for cancer therapy, Cancer Res, vol.65, pp.2993-2995, 2005.

H. Rochefort and E. Liaudet-coopman, Cathepsin D in cancer metastasis: A protease and a ligand, APMIS, vol.57, issue.1-6, pp.86-95, 1999.
DOI : 10.1111/j.1699-0463.1999.tb01530.x

V. Turk, J. Kos, and B. Turk, Cysteine cathepsins (proteases)--on the main stage of cancer? Cancer Cell, pp.409-410, 2004.

J. H. Greenbaum, M. Hager, D. Bogyo, and . Hanahan, Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis, Cancer Cell, vol.5, pp.443-453, 2004.

A. J. Barrett, Cathepsin D. Purification of isoenzymes from human and chicken liver, Biochemical Journal, vol.117, issue.3, pp.601-607, 1970.
DOI : 10.1042/bj1170601

S. Diment, K. J. Martin, and P. D. Stahl, Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins, J. Biol. Chem, vol.264, pp.13403-13406, 1989.

P. Briozzo, M. Morisset, F. Capony, C. Rougeot, and H. Rochefort, In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells, Cancer Res, pp.48-3688, 1988.

H. Umezawa, T. Aoyagi, H. Morishima, M. Matsuzaki, M. Hamada et al., PEPSTATIN, A NEW PEPSIN INHIBITOR PRODUCED BY AGTINOMYGETES, The Journal of Antibiotics, vol.23, issue.5, pp.259-262, 1970.
DOI : 10.7164/antibiotics.23.259

P. Metcalf and M. Fusek, Two crystal structures for cathepsin D: the lysosomal targeting signal and active site, EMBO J, vol.12, pp.1293-1302, 1993.

A. M. Collins, J. W. Silva, and . Erickson, Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design, Proc. Natl. Acad. Sci. USA 90, pp.6796-6800, 1993.

A. Y. Lee, S. V. Gulnik, and J. W. Erickson, Conformational switching in an aspartic proteinase, Nature Structural Biology, vol.64, issue.10, pp.866-871, 1998.
DOI : 10.1107/S0021889891007240

K. Ishidoh and E. Kominami, Processing and Activation of Lysosomal Proteinases, Biological Chemistry, vol.383, issue.12, pp.1827-1831, 2002.
DOI : 10.1515/BC.2002.206

J. Tang and R. N. Wong, Evolution in the structure and function of aspartic proteases, Journal of Cellular Biochemistry, vol.51, issue.1, pp.53-63, 1987.
DOI : 10.1002/jcb.240330106

W. A. Hsueh and J. D. Baxter, Human prorenin, Hypertension, vol.17, issue.4, pp.469-477, 1991.
DOI : 10.1161/01.HYP.17.4.469

G. Richo and G. E. Conner, Proteolytic Activation of Human Procathepsin D, Adv. Exp. Med. Biol, vol.306, pp.289-296, 1991.
DOI : 10.1007/978-1-4684-6012-4_35

G. E. Conner and G. Richo, Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D, Biochemistry, vol.31, issue.4, pp.31-1142, 1992.
DOI : 10.1021/bi00119a024

A. Hasilik and E. F. Neufeld, Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight, J. Biol. Chem, pp.255-4937, 1980.

G. Richo and G. E. Conner, Structural requirements of procathepsin D activation and maturation, J. Biol. Chem, vol.269, pp.14806-14812, 1994.

V. Figura and A. Hasilik, Lysosomal Enzymes and their Receptors, Annual Review of Biochemistry, vol.55, issue.1, pp.167-193, 1986.
DOI : 10.1146/annurev.bi.55.070186.001123

S. Kornfeld, Lysosomal enzyme targeting, Biochemical Society Transactions, vol.18, issue.3, pp.18-367, 1990.
DOI : 10.1042/bst0180367

M. Hentze, A. Hasilik, and K. Figura, Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog ??-hydroxynorvaline, Archives of Biochemistry and Biophysics, vol.230, issue.1, pp.375-382, 1984.
DOI : 10.1016/0003-9861(84)90120-6

A. M. Samarel, A. G. Ferguson, R. S. Decker, and M. Lesch, Effects of cysteine protease inhibitors on rabbit cathepsin D maturation, Am. J. Physiol, vol.257, pp.1069-1079, 1989.

S. Rijnboutt, A. J. Kal, H. J. Geuze, H. Aerts, and G. J. Strous, Mannose 6-phosphate- independent targeting of cathepsin D to lysosomes in HepG2 cells, J. Biol. Chem, pp.266-23586, 1991.

F. Capony, T. Braulke, C. Rougeot, S. Roux, P. Montcourrier et al., Specific Mannose-6-Phosphate Receptor-Independent Sorting of Pro-Cathepsin D in Breast Cancer Cells, Experimental Cell Research, vol.215, issue.1, pp.154-163, 1994.
DOI : 10.1006/excr.1994.1327

V. Gieselmann, A. Hasilik, and K. Figura, Processing of human cathepsin D in lysosomes in vitro, J. Biol. Chem, vol.260, pp.3215-3220, 1985.

M. J. Duffy, Proteases as prognostic markers in cancer, Clin. Cancer Res, vol.2, pp.613-618, 1996.

. Olsen, Neuronal loss and brain atrophy in mice lacking cathepsins B and L, Proc. Natl. Acad

F. Welte and . Buhling, Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells, Biol. Chem, vol.385, pp.665-670, 2004.

T. Kobayashi, K. Honke, S. Gasa, T. Fujii, S. Maguchi et al., Proteolytic processing sites producing the mature form of human cathepsin D, Int. J. Biochem, pp.24-1487, 1992.

A. H. Erickson and G. Blobel, Carboxyl-terminal proteolytic processing during biosynthesis of the lysosomal enzymes .beta.-glucuronidase and cathepsin D, Biochemistry, vol.22, issue.22, pp.22-5201, 1983.
DOI : 10.1021/bi00291a021

V. Laurent-matha, M. R. Farnoud, A. Lucas, C. Rougeot, M. Garcia et al., Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6- phosphate receptors, J. Cell. Sci, pp.111-2539, 1998.

V. Laurent-matha, A. Lucas, S. Huttler, K. Sandhoff, M. Garcia et al., Procathepsin D Interacts with Prosaposin in Cancer Cells but Its Internalization Is Not Mediated by LDL Receptor-Related Protein, Experimental Cell Research, vol.277, issue.2, pp.277-210, 2002.
DOI : 10.1006/excr.2002.5556

F. Vignon, F. Capony, M. Chambon, G. Freiss, M. Garcia et al., Autocrine Growth Stimulation of the MCF 7 Breast Cancer Cells by the Estrogen-Regulated 52 K Protein*, Endocrinology, vol.118, issue.4, pp.1537-1545, 1986.
DOI : 10.1210/endo-118-4-1537

M. J. Clague, Molecular aspects of the endocytic pathway, Biochemical Journal, vol.336, issue.2, pp.271-282, 1998.
DOI : 10.1042/bj3360271

A. Hasilik, K. Von-figura, E. Conzelmann, H. Nehrkorn, and K. Sandhoff, Lysosomal Enzyme Precursors in Human Fibroblasts. Activation of Cathepsin D Precursor in vitro and Activity of beta-Hexosaminidase A Precursor towards Ganglioside GM2, European Journal of Biochemistry, vol.78, issue.2, pp.125-317, 1982.
DOI : 10.1111/j.1432-1033.1982.tb06685.x

. Garcia, Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer, J. Steroid Biochem, vol.34, pp.177-182, 1989.

V. Cavaillès, P. Augereau, and H. Rochefort, Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells., Proc. Natl. Acad. Sci. USA 90, pp.203-207, 1993.
DOI : 10.1073/pnas.90.1.203

P. Augereau, M. Garcia, M. G. Mattei, V. Cavaillès, F. Depadova et al., Cloning and sequencing of the 52K cathepsin D cDNA of MCF7 breast cancer cells and mapping on chromosome 11, pp.186-192, 1988.

B. R. Westley and F. E. May, Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells, Nucleic Acids Research, vol.15, issue.9, pp.3773-3786, 1987.
DOI : 10.1093/nar/15.9.3773

V. Cavaillès, M. Garcia, and H. Rochefort, Regulation of Cathepsin-D and pS2 Gene Expression by Growth Factors in MCF7 Human Breast Cancer Cells, Molecular Endocrinology, vol.3, issue.3, pp.552-558, 1989.
DOI : 10.1210/mend-3-3-552

P. Augereau, F. Mirallès, V. Cavaillès, C. Gaudelet, M. Parker et al., Characterization of the proximal estrogen responsive element of human cathepsin D gene, Mol. Endocrinol, vol.8, pp.693-703, 1994.

F. Capony, C. Rougeot, P. Montcourrier, V. Cavaillès, G. Salazar et al., Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells, Cancer Res, pp.49-3904, 1989.

H. Rochefort, Cathepsin D in breast cancer: A tissue marker associated with metastasis, European Journal of Cancer, vol.28, issue.11, pp.1780-1783, 1992.
DOI : 10.1016/0959-8049(92)90003-K

B. R. Westley and F. E. May, Prognostic value of cathepsin D in breast cancer, British Journal of Cancer, vol.20, issue.2, pp.189-190, 1999.
DOI : 10.1038/sj.bjc.6690032

G. Ferrandina, G. Scambia, F. Bardelli, B. Panici, S. Mancuso et al., Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis, British Journal of Cancer, vol.76, issue.5, pp.661-666, 1997.
DOI : 10.1038/bjc.1997.442

J. A. Foekens, M. P. Look, J. Bolt-de-vries, M. Meijer-van-gelder, W. L. Van-putten et al., Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients, British Journal of Cancer, vol.32, issue.2, pp.300-307, 1999.
DOI : 10.1038/sj.bjc.6690048

P. Roger, P. Montcourrier, T. Maudelonde, J. P. Brouillet, A. Pagès et al., Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages. Correlation with cytosolic assay, Human Path, pp.25-863, 1994.

C. Escot, Y. Zhao, C. Puech, and H. Rochefort, Cellular localisation byin situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer, Breast Cancer Research and Treatment, vol.45, issue.2, pp.38-217, 1996.
DOI : 10.1007/BF01806676

H. Joensuu, S. Toikkanen, and J. Isola, Stromal cell cathepsin D expression and long-term survival in breast cancer, British Journal of Cancer, vol.71, issue.1, pp.155-159, 1995.
DOI : 10.1038/bjc.1995.32

M. Nadji, M. Fresno, M. Nassiri, G. Conner, A. Herrero et al., Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in nodenegative breast cancer, Hum. Pathol, pp.27-890, 1996.

A. E. O-'donoghue, D. N. Poller, J. A. Bell, M. H. Galea, C. W. Elston et al., Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells, Breast Cancer Res. Treat, pp.33-137, 1995.

B. Têtu, J. Brisson, H. Lapointe, C. S. Wang, P. Bernard et al., Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases, Breast Cancer Research and Treatment, vol.191, issue.2, pp.55-137, 1999.
DOI : 10.1023/A:1006140213493

. Rochefort, Increased cathepsin D level in serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay, Cancer, vol.79, pp.2132-2136, 1997.

D. E. Jarosz, P. J. Hamer, D. Y. Tenney, and J. R. Zabrecky, ELEVATED LEVELS OF PRO-CATHEPSIN-D IN THE PLASMA OF BREAST-CANCER PATIENTS, International Journal of Oncology, vol.6, pp.859-865, 1995.
DOI : 10.3892/ijo.6.4.859

M. Garcia, D. Derocq, P. Pujol, and H. Rochefort, Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency, Oncogene, vol.5, pp.1809-1814, 1990.

E. Liaudet, M. Garcia, and H. Rochefort, Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal, Oncogene, vol.9, pp.1145-1154, 1994.

E. Liaudet, D. Derocq, H. Rochefort, and M. Garcia, Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors, Cell Growth Differ, vol.6, pp.1045-1052, 1995.

. Coopman, A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells, Oncogene, vol.20, pp.6920-6929, 2001.

G. J. Berchem, M. Glondu, M. Gleizes, J. P. Brouillet, M. Garcia et al., Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis, Oncogene, vol.21, issue.38, pp.5951-5955, 2002.
DOI : 10.1038/sj.onc.1205745

M. Glondu, E. Liaudet-coopman, D. Derocq, N. Platet, H. Rochefort et al., Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells, Oncogene, vol.21, issue.33, pp.5127-5134, 2002.
DOI : 10.1038/sj.onc.1205657

M. Fusek and V. Vetvicka, Mitogenic function of human procathepsin D: the role of the propeptide, Biochemical Journal, vol.303, issue.3, pp.775-780, 1994.
DOI : 10.1042/bj3030775

V. Vetvicka, J. Vektvickova, and M. Fusek, Effect of human procathepsin D on proliferation of human cell lines, Cancer Letters, vol.79, issue.2, pp.131-135, 1994.
DOI : 10.1016/0304-3835(94)90251-8

V. Vetvicka, J. Vetvickova, and M. Fusek, Effect of procathepsin D and its activation peptide on prostate cancer cells, Cancer Letters, vol.129, issue.1, pp.55-59, 1998.
DOI : 10.1016/S0304-3835(98)00091-3

V. Vetvicka, J. Vetvickova, I. Hilgert, Z. Voburka, and M. Fusek, Analysis of the interaction of procathepsin D activation peptide with breast cancer cells, International Journal of Cancer, vol.20, issue.3, pp.403-409, 1997.
DOI : 10.1002/(SICI)1097-0215(19971104)73:3<403::AID-IJC15>3.0.CO;2-D

V. Vetvicka, J. Vetvickova, and M. Fusek, Anti???human procathepsin D activation peptide antibodies inhibit breast cancer development, Breast Cancer Research and Treatment, vol.264, issue.3, pp.261-269, 1999.
DOI : 10.1023/A:1006238003772

V. Vetvicka, J. Vetvickova, and M. Fusek, Role of procathepsin D activation peptide in prostate cancer growth, The Prostate, vol.107, issue.1, pp.1-7, 2000.
DOI : 10.1002/1097-0045(20000615)44:1<1::AID-PROS1>3.0.CO;2-4

P. Briozzo, J. Badet, F. Capony, I. Pieri, P. Montcourrier et al., MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin D, Experimental Cell Research, vol.194, issue.2, pp.252-259, 1991.
DOI : 10.1016/0014-4827(91)90362-X

D. B. Rifkin, Cross-talk among proteases and matrix in the control of growth factor action, Fibrinolysis and Proteolysis, vol.11, issue.1, pp.3-9, 1997.
DOI : 10.1016/S0268-9499(97)80003-3

J. R. Griffiths, Are cancer cells acidic?, British Journal of Cancer, vol.64, issue.3, pp.425-427, 1991.
DOI : 10.1038/bjc.1991.326

J. Folkman, Anti-Angiogenesis, Annals of Surgery, vol.175, issue.3, pp.409-416, 1972.
DOI : 10.1097/00000658-197203000-00014

M. S. Pepper, Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.21, issue.7, pp.1104-1117, 2001.
DOI : 10.1161/hq0701.093685

M. C. Gonzalez-vela, M. F. Garijo, F. Fernandez, L. Buelta, and J. F. , Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma, Histopathology, vol.70, issue.1, pp.35-42, 1999.
DOI : 10.1007/s004280050143

W. Morikawa, K. Yamamoto, S. Ishikawa, S. Takemoto, M. Ono et al., Angiostatin Generation by Cathepsin D Secreted by Human Prostate Carcinoma Cells, Journal of Biological Chemistry, vol.275, issue.49, pp.275-38912, 2000.
DOI : 10.1074/jbc.M005402200

D. Piwnica, P. Touraine, I. Struman, S. Tabruyn, G. Bolbach et al., Cathepsin D Processes Human Prolactin into Multiple 16K-Like N-Terminal Fragments: Study of Their Antiangiogenic Properties and Physiological Relevance, Molecular Endocrinology, vol.18, issue.10, pp.2522-2542, 2004.
DOI : 10.1210/me.2004-0200

B. Elenbaas and R. A. Weinberg, Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation, Experimental Cell Research, vol.264, issue.1, pp.169-184, 2001.
DOI : 10.1006/excr.2000.5133

L. A. Liotta and E. C. Kohn, The microenvironment of the tumor-host interface, Nature, vol.411, issue.6835, pp.375-379, 2001.
DOI : 10.1038/35077241

M. C. Chenard, P. Rio, and . Chambon, A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas, Nature, vol.348, pp.699-704, 1990.

A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Caroll, T. D. Tslty et al., Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium, Cancer Res, pp.59-5002, 1999.

M. P. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait, Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression, Cancer Res, pp.61-1320, 2001.

D. E. Ingber and J. Folkman, How does extracellular matrix control capillary morphogenesis?, Cell, vol.58, issue.5, pp.803-805, 1989.
DOI : 10.1016/0092-8674(89)90928-8

R. L. Juliano and S. Haskill, Signal transduction from the extracellular matrix, The Journal of Cell Biology, vol.120, issue.3, pp.577-585, 1993.
DOI : 10.1083/jcb.120.3.577

R. K. Assoian and E. E. Marcantonio, The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis., Journal of Clinical Investigation, vol.98, issue.11, pp.98-2436, 1996.
DOI : 10.1172/JCI119059

C. Q. Lin and M. J. Bissell, Multi-faceted regulation of cell differentiation by extracellular matrix, FASEB J, vol.7, pp.737-743, 1993.

J. E. Koblinski, J. Dosescu, M. Sameni, K. Moin, K. Clark et al., Interaction of human breast fibroblasts with collagen I increased secretion of procathepsin B, J. Biol. Chem, pp.277-32220, 2002.

T. Mckinnon, C. Chakraborty, L. M. Gleeson, P. Chidiac, and P. K. Lala, Stimulation of Human Extravillous Trophoblast Migration by IGF-II Is Mediated by IGF Type 2 Receptor Involving Inhibitory G Protein(s) and Phosphorylation of MAPK, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.8, pp.86-3665, 2001.
DOI : 10.1210/jcem.86.8.7711

N. Heylen, L. M. Vincent, V. Devos, V. Dubois, C. Remacle et al., Fibroblasts capture cathepsin D secreted by breast cancer cells: Possible role in the regulation of the invasive process, International Journal of Oncology, vol.20, pp.761-767, 2002.
DOI : 10.3892/ijo.20.4.761

J. A. Uria, M. Stahle-backdahl, M. Seiki, A. Fueyo, and C. Lopez-otin, Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions, Cancer Res, vol.57, pp.4882-4888, 1997.

L. Christensen, A. C. Wiborg-simonsen, C. W. Heegaard, S. K. Moestrup, J. A. Andersen et al., Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and ??2-macroglobulin receptor in human breast carcinomas, International Journal of Cancer, vol.354, issue.4, pp.441-452, 1996.
DOI : 10.1002/(SICI)1097-0215(19960516)66:4<441::AID-IJC6>3.0.CO;2-W

L. A. Liotta, P. S. Steeg, and W. G. Stetler-stevenson, Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation, Cell, vol.64, issue.2, pp.327-336, 1991.
DOI : 10.1016/0092-8674(91)90642-C

A. F. Chambers and L. M. Matrisian, Changing views of the role of matrix metalloproteinases in metastasis, JNCI Journal of the National Cancer Institute, vol.89, issue.17, pp.1260-1270, 1997.
DOI : 10.1093/jnci/89.17.1260

D. H. Carney and D. D. Cunningham, Role of specific cell surface receptors in thrombin-stimulated cell division, Cell, vol.15, issue.4, pp.1341-1349, 1978.
DOI : 10.1016/0092-8674(78)90059-4

F. Morisset and . Vignon, Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?, J. Cell. Biochem, vol.35, pp.17-29, 1987.

S. E. Kane and M. M. Gottesman, The role of cathepsin L in malignant transformation, Semin. Cancer Biol, vol.1, pp.127-136, 1990.

M. Mathieu, H. Rochefort, B. Barenton, C. Prebois, and . Vignon, Interactions of Cathepsin-D and Insulin-Like Growth Factor-II (IGF-II) on the IGF-II/Mannose-6-Phosphate Receptor in Human Breast CancerCells and Possible Consequences on Mitogenic Activity of IGF-II, Molecular Endocrinology, vol.4, issue.9, pp.1327-1335, 1990.
DOI : 10.1210/mend-4-9-1327

L. P. Deiss, H. Galinka, H. Berissi, and O. Cohen, Cathepsin D protease mediates programmed cell death induced by interferon gamma, Fas/APO-1 and TNF alpha, EMBO J, vol.15, pp.3861-3870, 1996.

G. S. Wu, P. Saftig, C. Peters, and W. S. , Potential role for Cathepsin???D in p53-dependent tumor suppression and chemosensitivity, Oncogene, vol.16, issue.17, pp.2177-2183, 1998.
DOI : 10.1038/sj.onc.1201755

K. Roberg and K. Ollinger, Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes, Am. J. Pathol, vol.152, pp.1151-1156, 1998.

K. Ollinger, Inhibition of Cathepsin D Prevents Free-Radical-Induced Apoptosis in Rat Cardiomyocytes, Archives of Biochemistry and Biophysics, vol.373, issue.2, pp.346-351, 2000.
DOI : 10.1006/abbi.1999.1567

K. Roberg, Relocalization of Cathepsin D and Cytochrome c Early in Apoptosis Revealed by Immunoelectron Microscopy, Laboratory Investigation, vol.181, issue.2, pp.149-158, 2001.
DOI : 10.1038/35060

K. Kagedal, U. Johansson, and K. Öllinger, The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress, The FASEB Journal, vol.15, pp.1592-1594, 2001.
DOI : 10.1096/fj.00-0708fje

K. Takuma, M. Kiriu, K. Mori, E. Lee, R. Enomoto et al., Roles of cathepsins in reperfusion-induced apoptosis in cultured astrocytes, Neurochemistry International, vol.42, issue.2, pp.42-153, 2003.
DOI : 10.1016/S0197-0186(02)00077-3

A. C. Johansson, H. Steen, K. Öllinger, and K. Roberg, Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine, Cell Death and Differentiation, vol.10, issue.11, pp.1253-1259, 2003.
DOI : 10.1038/sj.cdd.4401290

K. Roberg, K. Kagedal, and K. Ollinger, Microinjection of Cathepsin D Induces Caspase-Dependent Apoptosis in Fibroblasts, The American Journal of Pathology, vol.161, issue.1, pp.89-96, 2002.
DOI : 10.1016/S0002-9440(10)64160-0

W. Wickel, A. Schneider-brachert, A. Trauzold, S. Hethke, and . Schutze, Cathepsin D links TNFinduced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation, Cell Death Differ, vol.11, pp.550-563, 2004.

N. Bidère, H. K. Lorenzo, S. Carmona, M. Laforge, F. Harper et al., Cathepsin D Triggers Bax Activation, Resulting in Selective Apoptosis-inducing Factor (AIF) Relocation in T Lymphocytes Entering the Early Commitment Phase to Apoptosis, Journal of Biological Chemistry, vol.278, issue.33, pp.278-31401, 2003.
DOI : 10.1074/jbc.M301911200

A. Terman, J. Neuzil, K. Kagedal, K. Ollinger, and U. T. Brunk, Decreased Apoptotic Response of Inclusion-Cell Disease Fibroblasts: A Consequence of Lysosomal Enzyme Missorting?, Experimental Cell Research, vol.274, issue.1, pp.9-15, 2002.
DOI : 10.1006/excr.2001.5441

M. Demoz, R. Castino, P. Cesaro, F. M. Baccino, G. Bonelli et al., Endosomallysosomal proteolysis mediates death signalling by TNFalpha, not by etoposide, in L929 fibrosarcoma cells: evidence for an active role of cathepsin D, Biol. Chem, pp.383-1237, 2002.

S. Watanabe, K. Ebisu, E. Ishido, Y. Kominami, and . Uchiyama, Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation, Biochem. Biophys. Res. Commun, pp.251-199, 1998.

R. A. Gottlieb, J. Nordberg, E. Skowronski, and B. M. Babior, Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification., Proc. Natl. Acad. Sci. USA 93, pp.654-658, 1996.
DOI : 10.1073/pnas.93.2.654

S. Matsuyama, J. Llopis, Q. L. Deveraux, R. Y. Tsien, and J. C. Reed, Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis, Nat. Cell Biol, vol.2, pp.318-325, 2000.

F. Capony, M. Morisset, A. J. Barrett, J. P. Capony, P. Broquet et al., Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells, The Journal of Cell Biology, vol.104, issue.2, pp.253-262, 1987.
DOI : 10.1083/jcb.104.2.253

C. Tardy, J. Tyynela, A. Hasilik, T. Levade, and N. , Andrieu-Abadie, Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D, Cell Death Differ, pp.10-1090, 2003.

J. J. Jr-reiners, J. A. Caruso, P. Mathieu, B. Chelladurai, X. M. Yin et al., Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage, Cell Death and Differentiation, vol.187, issue.9, pp.934-944, 2002.
DOI : 10.1038/sj.cdd.4401048